Also from this source

You just read:

Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar

News provided by

Vicus Therapeutics, LLC

Dec 27, 2010, 08:02 EST